In the present pilot study, we investigated the systemic levels of MMPs (MMP1, MMP2, MMP3, MMP9) and TIMPs (TIMP1 and TIMP3) in patients with early AMD, nAMD, and PCV and normal control subjects. This evidence concerns the gene TIMP3 and age-related macular degeneration.